Form 4: Dyne Therapeutics COO Susanna Gatti High Sells Shares to Cover Tax Obligations

Dyne Therapeutics' Chief Operating Officer, Susanna Gatti High, sold shares of common stock to cover tax withholding obligations and other transactions.

Summary

• Susanna Gatti High, the Chief Operating Officer of Dyne Therapeutics, Inc., reported the sale of common stock in multiple transactions.
• On March 8, 2024, she sold 26,908 shares at a weighted average price of $26.66 and 291 shares at a weighted average price of $27.41.
• On March 11, 2024, she sold 2,292 shares at a weighted average price of $25.7 to satisfy tax withholding obligations related to vesting restricted stock units.
• Following these transactions, High beneficially owns 156,800 shares of Dyne Therapeutics, Inc., including 145,829 unvested RSUs.

Sentiment

Score: 5

Explanation: The document reflects routine stock sales by an executive, primarily to cover tax obligations, which is neither particularly positive nor negative.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies and are often related to personal financial planning or tax obligations.

Stakeholder Impact

• The stock sales could have a minor, temporary impact on the stock price, but are unlikely to significantly affect long-term shareholder value.

Key Dates